Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205

Cancer Chemotherapy and Pharmacology

Volumn 79, Issue 2, 2017, Pages 327-337

  Zhang, Hong Yan ^a   Liang, Feng ^b   Zhang, Jian Wei ^a   Wang, Fei ^a   Wang, Li ^a   Kang, Xi Gang ^a  

^a PLA ARMY GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Breast cancer; Long noncoding RNA ROR; MicroRNA 205; Tamoxifen resistance

Indexed keywords

BETA ACTIN; CHOLECYSTOKININ OCTAPEPTIDE; LONG UNTRANSLATED RNA; MICRORNA 205; TAMOXIFEN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; VIMENTIN; HOMEODOMAIN PROTEIN; LINC-RNA-ROR, HUMAN; MESSENGER RNA; MICRORNA; MIRN205 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN; ZINC FINGER E BOX BINDING HOMEOBOX 2;

ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CELL INVASION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FILTERS AND MEMBRANES; GENE EXPRESSION REGULATION; HUMAN; IN VITRO STUDY; LENTIVIRINAE; MCF-7 CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; WESTERN BLOTTING; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENETICS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; RNA, LONG NONCODING; RNA, MESSENGER; TAMOXIFEN; ZINC FINGER E-BOX BINDING HOMEOBOX 2; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 85008448634     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-016-3208-2     Document Type: Article

References (31)

1. Igene H (2008) Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J 14:428–434
2. Travis RC, Reeves GK, Green J et al (2010) Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet 375:2143–2151
3. Zheng S, Bai JQ, Li J et al (2012) The pathologic characteristics of breast cancer in China and its shift during 1999–2008: a national-wide multicenter cross-sectional image over 10 years. Int J Cancer 131:2622–2631
4. Jordan VC, O’Malley BW (2007) Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 25:5815–5824
5. Lewis JS, Jordan VC (2005) Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat Res 591:247–263
6. Carroll JS, Brown M (2006) Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20:1707–1714
7. Zafra-Ceres M, de Haro T, Farez-Vidal E et al (2013) Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer. Int J Med Sci 10:932–937
8. Hung T, Chang HY (2010) Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 7:582–585
9. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361
10. Brunner AL, Beck AH, Edris B et al (2012) Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol 13:R75
11. Zhang A, Zhou N, Huang J et al (2013) The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 23:340–350
12. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q (2015) lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res (MCR) 13:330–338
13. Feng S, Yao J, Chen Y et al (2015) Expression and functional role of reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J Mol Neurosci (MN) 56:623–630
14. Kim J, Lee J, Jang SY, Kim C, Choi Y, Kim A (2016) Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines. Oncol Rep 35:2553–2560
15. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Investig 119:1420–1428
16. Hiscox S, Jiang WG, Obermeier K et al (2006) Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118:290–301
17. Bremnes RM, Veve R, Hirsch FR, Franklin WA (2002) The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36:115–124
18. Schepens B, Tinton SA, Bruynooghe Y, Beyaert R, Cornelis S (2005) The polypyrimidine tract-binding protein stimulates HIF-1alpha IRES-mediated translation during hypoxia. Nucleic Acids Res 33:6884–6894
19. Galban S, Kuwano Y, Pullmann R Jr et al (2008) RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol 28:93–107
20. Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465–472
21. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593–601
22. Hurteau GJ, Spivack SD, Brock GJ (2006) Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle 5:1951–1956
23. Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH (2007) miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 13:1172–1178
24. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67:7972–7976
25. Sanchez-Tillo E, Siles L, de Barrios O et al (2011) Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res 1:897–912
26. Gheldof A, Hulpiau P, van Roy F, De Craene B, Berx G (2012) Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci (CMLS) 69:2527–2541
27. Vandewalle C, Van Roy F, Berx G (2009) The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci (CMLS) 66:773–787
28. Kato M, Zhang J, Wang M et al (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104:3432–3437
29. Baffa R, Fassan M, Volinia S et al (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219:214–221
30. Takahashi K, Yan IK, Haga H, Patel T (2014) Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 127:1585–1594
31. Kent OA, McCall MN, Cornish TC, Halushka MK (2014) Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucl Acids Res 42:7528–7538